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ABSTRACT 
Fast dissolving tablet have potential advantages over conventional dosage forms, which has helped patient compliance, convenience, 
bioavailability and rapid onset of action. These are very good for drug delivery over geriatric and pediatric patients. They have significant 
advantages of solid and liquid dosage forms, because when they are in solid form and when transformed into liquid form and within few 
seconds after it is consumed. With new technologies for it formulation many commercial products are available in the market for the patients. 
So FDT have awful scope for being the delivery system. Therefore in the present investigation, starch based superdisintegrant was prepared 
and evaluated for its application in the design of fast dissolving dosage forms of piroxicam. 
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INTRODUCTION: 
Fast dissolving tablets are solid dosage forms containing 
medicinal substances which disintegrate rapidly, usually 
within few seconds when placed upon tongue requiring no 
additional water, to facilitate swallowing. Various 
techniques can be used to formulate fast dissolving tablets. 
Direct compression method, one of most oldest and 
convenient method of formulating tablets. Direct 
compression method needs only the cheaper excipients. 
Therefore the dosage forms which were formulated by 
direct compression method will be cheaper than the dosage 
forms formulated by other methods. The aim of the work 
was to formulate and evaluate fast dissolving tablets of 
piroxicam employing modified starch as a superdisintegrant 
for rapid dissolution and absorption of drugs, which may 
produce the rapid onset of action of drug. 
Optimization technique 
Optimization techniques facilitate the clear understanding 
and can be ability to explore and define ranges for 
formulation and processing factors with a careful approach 
for the selection of several experimental and manufacturing 
steps for a given product.  
The present study deals with the investigation for 
optimization of piroxicam fast dissolving tablets employing 
modified starch, crosscaramallose sodium, and crospovidone 
as superdisintegrants. A 23 factorial design was applied to 
investigate the main and interaction effects of the three 
formulation variables that is, modified starch (A), 
crosscaramallose sodium (B) and crosprovidone (C) in each 
case to find the formulation with less disintegration time and 
more dissolution efficiency in 5 min and permit and 
arbitrary detection of tablets with immediate release of drug 
within ten minutes.  
MATERIALS & METHODS 
1. Piroxicam (Yarrow chemicals, Mumbai). 
2. Modified starch (Synthesized in laboratory). 
3. Croscarmellose sodium (Yarrow chemicals, Mumbai). 
4. Crospovidone (Yarrow chemicals, Mumbai) 
5. Mannitol ( Yarrow chemicals, Mumbai) 
6. Microcrystalline cellulose (Quligens fine chemicals, 
Mumbai). 
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7. Talc (Molychem, Mumbai) 
8. Magnesium stearate  (Molychem, Mumbai) 
Preparation of modified starch acid:  
Initially10 grams of glutaric acid was dissolved in distilled 
water and the pH was adjusted to 3.5 using 10M sodium 
hydroxide and finally made up to 25 ml. To the above 
mixture 25 grams potato starch was added and conditioned 
for 16 hrs at room temperature, later the product was kept 
in oven at 600C for 6 hrs, the mass was washed to remove un 
reacted glutaric acid. After washing the product was dried at 
600C. The product obtained was ground and sieved (# 100). 
Preparation of Piroxicam Fast Dissolving Tablets: 
The tablets were prepared by direct compression method. 
The composition of formulations of piroxicam fast dissolving 
tablets is shown in table no 1. For uniformity in particle size 
each ingredient was passed through # 100 mesh sized 
screen before mixing. Modified starch, 
croscarmellosesodium, crosprovidone, mannitol, 
microcrystalline cellulose, were accurately weighed and 
mixed using motor and pestle, and then added to piroxicam. 
Finally talc and magnesium stearate were added to the 
powder. Finally mixed blend was compressed by using eight 
station rotator press (Shakthi Machinineries Pvt. Ltd., 
Ahmadabad).  
Evaluation of Piroxicam Fast Dissolving Tablets:  
Hardness: [1].   
The hardness of the tablet is the force required to break a 
tablet in a diametric compression force. The hardness tester 
used in the study was Monsanto hardness tester, which 
applies force to the tablet diametrically with the help of an 
inbuilt spring and expressed in kg/cm2. 
Uniformity of Weight: [1]. 
Weight variation test was done with 20 tablets. It is the 
individual variation of tablet weight form the average weight 
of 20 tablets. 
Average weight of tablet % Deviations 
80 mg or less ±10 
More than 80 mg or less than 250 mg ±7.5 
More than 250 mg ± 5 
 
Friability: [1].   
The friability of tablets was measured using a Roche 
friabilator. Tablets were rotated at 25 rpm for 4 minutes or 
to 100 revolutions. The tablets were then reweighed after 
removal of fines and the percentage of weight of weight loss 
was calculated. 
            
                   
          
      
Drug Content Uniformity: [2]. 
For content uniformity test, ten tablets were weighed and 
powdered. A quantity of powder equivalent to 100 mg of 
piroxicam was extracted into 0.1N hydrochloric acid buffer 
and filtered. The piroxicam content was determined by 
measuring the absorbance spectrophotometrically at 333 
nm after appropriate dilution with 0.1N hydrochloric acid 
buffer. The drug content was calculated using the standard 
calibration curve. The mean percentage drug content was 
calculated as an average of three determinations.  
Wetting Time: [3]. 
The wetting time of the tablet was noted as the time taken 
by the water to reach the upper surface of the tablet, when 
the tablet is placed in water. The wetting time of the tablets 
was measured using a very simple process. Five circular 
tissue papers were placed in a petridish with a 10 cm 
diameter. Ten milliliters of water containing soluble dye 
(Amaranth) was added to the petridis and a fast dissolving 
tablet was carefully placed on the surface of paper. The time 
taken by to tablet to become red is noted as wetting time. 
Water Absorption Ratio: [4]. 
Initially the fast dissolving tablet was weighed. Then tablet 
was put on the tissue paper which was folded twice a small 
petridish a containing 6 ml of water, and allowed to wet 
completely. The wetted tablet was then weighted. Water 
absorption ratio, R was determined using following 
equation. 
    
          
  
 
Where  
W1 = weight of tablet after water absorption 
W2= weight of tablet before water absorption 
In vitro Disintegration Time: [5]. 
Disintegration time for FDTs was determined using USP 
disintegration apparatus with pH 0.1N hydrochloric acid 
buffer. The volume of medium was 900 ml and temperature 
was 37±0.20C. The time in seconds taken for complete 
disintegration of the tablet with no palatable mass 
remaining in the apparatus was measured. 
In Vitro Dissolution Rate Studies: [5]. 
The in vitro dissolution  rate study of piroxicam  fast  
dissolving tablets was performed using 8 station dissolution 
test apparatus (Electro lab TDT- 08L) fitted with paddles (50 
ppm) at 37 ± 0.50 C, using pH 0.1N hydrochloric acid (900 
ml) as a dissolution media. At the predetermined time 
intervals 5 ml sample was withdrawn, filtered through 0.45 
µ membrane filter, diluted and assayed at 333 nm using a 
Analytical technology Elico SL 191 UV/Visible Double beam 
spectrophotometer. Cumulative percentage drug dissolved 
was calculated using standard absorbance from the 
calibration curve. All the dissolution experiments were 
conducted in triplicate (n=3).  
Optimization: 
The percentages of modified starch (A), croscarmellose 
sodium (B) and crospovidone (C) were selected as 
independent variables. The dissolution efficiency in 5 
minutes was selected as dependent variable. The resulting 
data was fitted into Stat Ease, Inc. (Minneapolis, MN) Design 
Expert 11 Version software and analyzed statistically using 
analysis of Variance (ANOVA). The data were also subjected 
to 3-D response surface methodology to determine the 
influence of modified starch, croscarmellose sodium, 
crospovidone and interactions between them on dependent 
variable. 
Comparison of Optimized formula with the Marketed 
Sample: 
The optimized formula will be compared with the marketed 
formula for all its physical properties and dissolution 
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parameters. The marketed sample available in the local 
market was 
 MOBICAM-DT 
B.NO. B670823                  
MFG. AUG.2017  Exp. JUL.20  
CIPLA 
Mfg. by. Cipla. LTD. 
Village tanda mallu, Kosing.road 
Ram Nagar (Dist)
 
Table 1: Formulation of Piroxicam Fast Dissolving Tablets Employing Modified starch 
Ingredients 
(mg/tablet) 
F1 F2 F3 F4 F5 F6 F7 F8 
Piroxicam 20 20 20 20 20 20 20 20 
Modified Starch - 10 - 10 - 10 - 10 
Croscarmellose sodium - - 10 10 - - 10 10 
Crospovidone - - - - 10 10 10 10 
Mannitol 72 62 62 52 62 52 52 42 
Micro crystalline cellulose 100 100 100 100 100 100 100 100 
Talc 4 4 4 4 4 4 4 4 
Magnesium stearate 4 4 4 4 4 4 4 4 
Total weight 200 200 200 200 200 200 200 200 
 
Table 2: Physical properties: Hardness, Friability, Drug Content, Wetting Time, Water Absorption Ratio of Piroxicam 
Fast Dissolving Tablets. 
Formul-
ation 
code 
Hardness 
(Kg/Cm2) 
±S.D 
Friability 
(%)±S.D 
Drug Content± 
S.D 
Disintegration 
Time (S)±S.D 
Wetting 
Time 
(sec)±S.D 
Water 
Absorption 
Ratio(%)±S.D 
F1 3.7±0.01 0.12±0.013 19.85±0.1 10818±0.6 285±0.2 0.44±0.1 
F2 3.7±0.03 0.13±0.015 19.21±0.2 53±0.5 22±0.12 1.89±0.18 
F3 3.7±0.01 0.14±0.012 19.16±0.2 210±0.02 120 ±0.09 1.77±0.16 
F4 3.7±0.04 0.12±0.014 19.56±0.16 325±0.02 176±0.02 1.16±0.15 
F5 3.8±0.03 0.14±0.012 19.83±0.26 380±0.01 158±0.21 1.77±0.21 
F6 3.9±0.01 0.15±0.012 19.34±0.12 323±0.02 42±0.09 1.22±0.12 
F7 3.8±0.02 0.14±0.014 19.65±0.7 102±0.01 33±0.13 1.15±0.15 
F8 3.7±0.04 0.12±0.013 19.27±0.11 132±  0.02 26±0.1 1.55±0.27 
*SD standard deviation from mean, n=3, mean±SD. 
 
 
Fig: 1(a) Wetting Times of Piroxicam Fast Dissolving Tablets Formulated Employing Modified 
Starch - (A Novel Superdisintegrant) 
F1 Piroxicam Fast Dissolving Tablets 
  
At T=0 sec At T=285 sec 
F2 Piroxicam Fast Dissolving Tablets 
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Fig: 1(b) Wetting Times of Piroxicam Fast Dissolving Tablets Formulated Employing Modified 
Starch - (A Novel Superdisintegrant) 
At T=0 sec At T=22 sec 
F3 Piroxicam Fast Dissolving Tablets 
  
At T=0 sec At T=120 sec 
F4 Piroxicam Fast Dissolving Tablets 
  
At T=0 sec At T=176 sec 
F5 Piroxicam Fast Dissolving Tablets 
  
At T=0 sec At T=158 sec 
F6 Piroxicam Fast Dissolving Tablets 
  
          At T=0 sec At T=42 sec        
F7 Piroxicam Fast Dissolving Tablets 
  
           At T=0 At T=33 sec                         
F8 Piroxicam Fast Dissolving Tablets 
  
          At T=0 At T=26 sec 
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Table: 3. Piroxicam Dissolution Data of Fast Dissolving Tablets Employing Modified Starch 
 
*SD standard deviation from mean, n=3, mean±SD. 
 
Fig. 2: Dissolution Profiles of Piroxicam Fast Dissolving 
Tablets Employing Modified Starch (F1 to F4) 
 
Fig. 3: Dissolution Profiles of Piroxicam Fast Dissolving 
Tablets Employing Modified Starch. (F5 to F8) 
 
 
Fig 4: Log Time Vs Log Percent Undissolved Piroxicam 
Fast Dissolving Tablets Employing Modified Starch 
Prepared By Direct Compression Method (F1 to F4) 
 
Fig 5: Log Time Vs Log Percent Undissolved Piroxicam 
Fast Dissolving Tablets Employing Modified Starch 
Prepared by Direct Compression Method (F5 to F8)
Piroxicam Percent Dissolved from Fast Dissolving Tablets Employing Modified Starch 
Time 
(Min) 
F1 F2 F3 F4 F5 F6 F7 F8 
5 5.1± 0.1 85.12±0.2 46.77±0.3 39.5±0.3 44.21±0.2 40.11± 1.3 65.02±0.6 74.62±2.3 
10 7.3±2.1 99.89±0.4 50.71±2.1 39.85±2.1 47.12±1.3 41.3±2.1 70.37±1.2 84.09±0.2 
15 11.2±2.3 - 52.9±3.2 46.79±1.3 50.32±0.5 44.7±1.3 73.48±0.6 86.36±3.1 
30 16.5±0.3 - 55.84±0.5 45 ±2.3 51.77±0.6 47.12±2.3 84.91±0.5 93.37±0.6 
45 20.6±0.5 - 61.65±0.6 56.36±2.6 53.25±0.3 65.95±0.2 93.54±0.4 99.44±1.3 
60 22.4±0.2 - 68.92±0.5 61.86±3.1 57.12±0.6 76.51±0.6 99.62±1.5             - 
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Table 4: Dissolution Parameters of Piroxicam Fast Dissolving Tablets Formulated Employing Modified Starch  
Parameter F1 F2 F3 F4 F5 F6 F7 F8 
PD5 5.1±0.1 85.12±0.2 46.77±0.3 39.50±0.3 44.21±0.2 40.11±1 74.62±0.3 65.02±0.6 
DE5 (%) 3.6±0.01 83.3±0.03 43.4±0.02 37.2±0.01 41.9±0.02 37±0.03 72.5±0.04 62.6±0.05 
Increase in DE5 
(%) No. of folds 
- 23.13 12.05 10.33 11.63 10.27 20.13 17.38 
K1 (min-1) 0.01±0.01 0.06±0.02 0.18±0.12 7.6±0.03 2.3±0.05 0.01±0.05 0.04±0.2 0.05±0.01 
Increase in K1 
(min-1) No. of 
folds 
- 6 18 760 230 1 4 5 
*SD standard deviation from mean, n=3, mean±SD, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., K1 
=First order rate constant 
 
RESULTS AND DISCUSSION 
Fast dissolving tablets each containing 20 mg of piroxicam 
could be prepared by employing modified starch and other 
known superdisintegrants, croscarmellose sodium and 
crosprovidone by direct compression method. Hardness of 
the tablets was in range of 3.7-3.9 kg/sq.cm. It indicates good 
strength with a capability to resist physical and pre 
functionary stress condition during handling. Weight loss on 
the friability test was less than 0.16% in all cases. All the fast 
dissolving tablets prepared containg piroxicam with in 
100±5% of the labeled claim. As such the prepared tablets 
were of good quality with respect to drug content, hardness 
and friability. The disintegration time of all formulated 
tablets was found to be in the range of 53±0.05 to 
10818±0.06 seconds as indicated in the table: 2. The F2 
formulation containing 5% novel superdisintegrant i.e. 
modified starch disintegrated rapidly. 
The results in-vitro wetting time and water absorption ratio 
were found to be within prescribed limits and satisfy the 
criteria of fast dissolving tablets (Fig.5). The in-vitro wetting 
time was decreased when the superdisintegrant was used. In 
the case of formulation F2 modified starch, the wetting item 
found to be 22±0.12sec, indicating the suitability of modified 
starch as novel superdisintegrant.  
To evaluate the individual and combined effects of the 
factors involved, fast dissolving tablets were formulated 
employing selected combination of the factors as per 23- 
factorial design. The disintegration wetting time and release 
parameters (percent drug dissolved in 10 min and 
dissolution efficiency in 5 min) of the fast dissolving tablets 
formulated were analyzed as per ANOVA of 23- factorial 
design indicated that the individual, effects of modified 
starch (A), croscarmellose sodium (B), and crospovidone (C) 
as well as the combined effect of AB, AC, BC and (ABC) 
factors was significant on all the parameters analyzed. With 
in 53±0.5 seconds indicating the suitability of modified 
starch as superdisintegrants.  
 
 
TABLE-5 ANOVA of Disintegration Time of Piroxicam Fast Dissolving Tablets 
Source of variation d. f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 2704.75 1352.37 22.80        
Treatments 7 21395501 3056500.14 5153.31        
Modified Starch(A) 1 761484.37 761484.37 12839.05        
 
Croscarmellose sodium (B) 
 
1 
 
65626.04 
 
65626.04 
 
1106.49 
 
       
 
Modified starch  x Croscarmellose (AB)  
 
1 
 
474609.37 
 
474609.37 
 
8002.18 
 
       
Crospovidone (C) 1 408465.04 408465.04 6886.95        
Modified starch  x Crospovidone (AC) 1 832165.04 832165.04 14030.77        
   
Croscarmellose x Crospovidone (BC) 
 
1 
 
65626.04 
 
65626.04 
 
1106.49 
 
       
 
Modified starch  x Croscarmellose x 
Crospovidone  (ABC) 
 
 
1 
 
 
474609.37 
 
 
474609.37 
 
 
8002.18 
 
 
       
Error  14 830.46 59.31     --- --- 
Total 23 8.27 0.35      --- --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance
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TABLE-6 ANOVA of Water Absorption Ratio of Piroxicam Fast Dissolving Tablets 
Source of variation d. f S.Ss M.S.S Variance 
ratio 
Result 
Replicates 2 39.58 19.791 3.564        
Treatments 7 180847.62 25835.37 4652.50        
Modified Starch(A) 1 69660.37 69660.37 12544.62        
Croscarmellose sodium (B) 1 8400.04 8400.04 1512.70        
Modified starch  x 
Croscarmellose sodium x(AB) 
1 36738.37 36738.37 6615.94        
Crospovidone (C) 1 42588.37 42588.37 7669.43        
Modified starch  x 
Crospovidone (AC) 
1 13490.04 13490.04 2429.32        
Croscarmellose sodium x  
Crospovidone (BC) 
1 6633.37 6633.37 1194.55        
Modified starch  x 
Croscarmellose sodium x  
Crospovidone (ABC) 
1 3337.04 3337.04  600.94        
Error 14 77.75 5.553      ---    --- 
Total 23 180964.95 7868.04      ---    --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
TABLE-7 ANOVA of Percent Drug Dissolved In 5 Minutes of Piroxicam Fast Dissolving Tablets 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
Source of variation d. f S.S M.S.S Variance ratio Result 
Replicates 2 595955 29797.5 156.78        
Treatments 7 111309.33 1590.33 83.52        
Modified Starch(A) 1 3607.87 3607.87 18.94        
Croscarmellose sodium (B) 1 1374.4093 1374.4093 7.2        
Modified starch  x Croscarmellose sodium x (AB) 1 2171.703 2171.703 11.40        
Crospovidone (C) 1 890.3580 890.3580 4.67        
Modified starch  x Crospovidone(AC) 1 2041.67 2041.67 10.72        
Croscarmellose sodium x  Crospovidone ( BC) 1 1052.05 1052.05 5.5        
Modified starch  x Croscarmellose sodium x  
Crospovidone (ABC) 
1 1597.07 1597.07 8.3        
Error 14 2665.76 190.41 --- --- 
Total 23 12672.54   550.9802 --- --- 
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TABLE-8 ANOVA of Dissolution Efficiency in 5 Min of Piroxicam Fast Dissolving Tablets 
Source of variation d.f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 111.26 55.98 7.23        
Treatments 7 12902.45 1843.23 255.97        
Modified Starch(A) 1 4425.45 4425.45 571.76        
Croscarmellose sodium (B) 1 1139.88 1139.88 147.27        
Modified starch  x Croscarmellose sodium (AB)  1 1780.20 1780.20 230        
Crospovidone (C) 1 1058.68 1058.68 136.78        
Modified starch  x Crospovidone (AC) 1 670.98 670.98 86.69        
Croscarmellose sodium x Crospovidone (BC) 1 1014 1014 131.68        
Modified starch  x Croscarmellose sodium x  
Crospovidone (ABC)  
1 3717.57 3717.57 480.30        
Error 14 108.49 7.74 --- --- 
Total 23 544053.77 23654.51 --- --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
ANOVA of disintegration time, wetting time, percent drug 
dissolved and dissolution efficiency in 5 min (Table: 7.5, 7.6, 
7.7, 7.8) indicated that the individual effect as well as 
combined effects of the three factors (i.e., modified starch, 
croscarmellose sodium and crospovidon) were all significant  
(p<0.05). The ANOVA results, thus indicated that the three 
factors have significantly influence the disintegration time, 
wetting time, percent dissolved in 10 min and dissolution 
efficiency in 5min. 
 Piroxicam fast dissolving tablets (F2) formulated employing 
modified starch (5%), as novel superdisintegrant exhibited 
good disintegration and dissolution efficiency in 5 min. 
Formulation F2 gave release of 99.89±12%in 10 min fulfilling 
the official specification, based on disintegration on time and 
dissolution efficiency in 5 min,. F2 is considered as a good 
fast dissolving tablet formulation of piroxicam. 
A polynomial regression algorithm was used to relate the 
independent variables to the response variables. The general 
second order model equation that could be constructed from 
2n experimental design is in indicated in equation (1). 
Y= β0 + β1A + β2B + β3C + β1β2 AB + β1 β3 AC + β2β3 BC + β1β2 
β3 ABC ---- Eq(1). 
Where Y is the measured response, β0 is the arithmetic mean 
response of 8 runs , β1, β2, β3, β1β2, β1 β3, β2β3, β1β2 β3 are the 
coefficients for the corresponding factors, and A, B, C, AB, AC, 
BC and ABC are the percentages of modified starch (A) ,  
croscarmellose sodium (B) and crospovidone (C) and 
interaction terms respectively. The co-efficients were 
calculated according to the general formula given in equation  
27. 
β = Σ XY/2n                                                 ----Eq (2) 
where β is the coefficient, X is the corresponding variable 
(A,B,C) and Y is the response value (dissolution efficiency in 
5 minutes) and n is the level. 
The two levels of the three factors employed in the 
experimental design are indicated in Table 9 and 
transformed design for analysis of responses of piroxicam 
fast dissolving tablets is shown in Table 10. 
 
Table 9: Levels of the three factors used in the experimental design 
Factors Levels 
Ingredient Code L1 L2 
Modified Starch A 0 5 
Croscarmellose sodium B 0 5 
Crospovidone C 0 5 
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Table 10: Transformed design for analysis of responses of Piroxicam Fast Dissolving Tablets 
Formula code A(%) B(%) C(%) 
F1 0 0 0 
7F2 5 0 0 
F3 0 5 0 
F4 5 5 0 
F5 0 0 5 
F6 5 0 5 
F7 0 0 5 
F8 5 5 5 
 
The dissolution efficiency in 5 minutes, dissolution data 
clearly indicate that the dependent variables are strongly 
dependent on the independent variables. The fitted 
equations relating the response dissolution efficiency in 5 
minutes to the transformed factor is shown in equations 3. 
Final Equation in Terms of Coded Factors: 
Dissolution efficiency in 5 minutes = 
+47.69+9.81A+6.24B+5.81C-8.89AB-8.56AC+ 
7.81BC+12.59ABC(R2 = 1.000)                               ---Eq (3) 
The value of the R2 indicates a good fit. The polynomial 
equations can be used to draw a conclusion after considering 
the magnitude of coefficient and the mathematical sign it 
carries (positive or negative). 
From the polynomial equations, one can easily deduce that 
the effect of interactions between modified starch and 
croscarmellose sodium (AB); modified starch and 
crospovidone (AC); croscarmellose sodium and 
crospovidone (BC) are significant on the dissolution 
efficiency in 5 minutes but negatively in case of interaction 
between A&B, and A&C, but positively in case of interaction 
between B&C. On contrary, the magnitudes of coefficients of 
modified starch (A), croscarmellose sodium (B), 
crospovidone (C) and interaction between modified starch, 
croscarmellose sodium and crospovidone (ABC) are larger 
and positive, showing that the  dissolution efficiency in 5 
minutes of piroxicam fast dissolving tablets is affected by all 
A, B, C and ABC in positive manner. The equation for 
dissolution efficiency in 5 minutes suggests that the factor A 
has more significant effect on dissolution efficiency in 5 
minutes followed by factor B, C.                 
 Once, the polynomial equation which relates the levels of 
each factor and their corresponding interactions with 
dissolution efficiency in 5 minutes was derived, the surface 
response curves and contour plots were constructed using 
Stat Ease, Inc. (Minneapolis, MN) Design Expert  11 Version 
software. 
 
Fig.6: (A) Response Surface Plot (B) Contour Plot of Piroxicam Fast dissolving tablets. (effect of Modified starch and 
Croscarmellose sodium on Dissolution efficiency in 5 minutes). 
 
(A) Response Surface Plot 
 
(B) Contour Plot 
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Fig.7: (A) Response Surface Plot (B) Contour Plot of Piroxicam Fast dissolving tablets. (effect of Modified starch and 
Crospovidone on Dissolution efficiency in 5 minutes). 
 
(A) Response Surface Plot 
 
(B) Contour Plot 
 
Fig.8: (A) Response Surface Plot (B) Contour Plot of Piroxicam Fast dissolving tablets. (effect of Crospovidone and 
Croscarmellose sodium on Dissolution efficiency in 5 minutes) 
 
(A) Response Surface Plot 
 
(B) Contour Plot 
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The response surface plots and contour plots reveal that as 
the concentration of modified starch (A) increases, 
dissolution efficiency in 5 minutes increases. The other two 
variables also croscarmellose sodium (B) and crospovidone 
(C) have a positive effect on dissolution efficiency in 5 
minutes i.e., as the concentrations of B and C increases, 
dissolution efficiency in 5 minutes also increases. The effects 
of A and B on dissolution efficiency in 5 minutes are shown 
in Fig 6. The contour plots were found to be almost linear 
indicating a linear relationship between A and B on 
dissolution efficiency in 5 minutes. It was determined from 
the contour plot (Fig 6 B), that a higher dissolution efficiency 
in 5 minutes can be obtained with an A level range between 
4 to 5 %, and a B level range from 4-5 %. It is evident from 
contour plot that the high levels of A and high levels of B 
favors dissolution efficiency in 5 minutes of piroxicam fast 
dissolving tablets. The effects of A and C on dissolution 
efficiency in 5 minutes are shown in Fig 7. The contour plots 
were found to be linear indicating a linear relationship 
between A and C on dissolution efficiency in 5 minutes. It 
was determined from the contour plot (Fig. 7 B), that a 
higher dissolution efficiency in 5 minutes can be obtained 
with an A level range between 4 to 5 %, and a C level range 
from 4 – 5 %. It is evident from contour plot that the low 
levels of A and high levels of C favors dissolution efficiency 
in 5 minutes of piroxicam fast dissolving tablets. The effects 
of B and C on dissolution efficiency in 5 minutes are shown 
in Fig 8. The contour plots were found to be linear indicating 
a linear relationship between B and C on dissolution 
efficiency in 5 minutes. It was determined from the contour 
plot (Fig. 8 B) that higher dissolution efficiency in 5 minutes 
can be obtained with a B level range between 4 to 5 %, and a 
C level range from 4-5 %. It is evident from contour plot that 
the high levels of B and C favors dissolution efficiency in 5 
minutes of piroxicam fast dissolving tablets.  
Comparison of Optimized Piroxicam acid Fast Dissolving 
Tablet (F2) with the Marketed Sample (Mobicam) : 
The optimized formula was compared with the marketed 
formula ( Mobicam).  The physical properties of optimized 
piroxicam fast dissolving tablets (F2) and the marketed 
formulation (MOBICAM) were almost similar. 
  
Table 11: Physical properties: Hardness, Friability, Drug Content, Wetting Time, Water Absorption Ratio of Optimized 
Piroxicam Fast Dissolving Tablet (F2) employing modifies starch and Marketed Formulation (Mobicam). 
Formul-
ation 
code 
Hardness 
(Kg/Cm2) 
±S.D 
Friability 
(%)±S.D 
Drug 
Content±S.D 
Disintegration 
Time (S)±S.D 
Wetting 
Time 
(sec)±S.D 
Water 
Absorption 
Ratio(%)±S.D 
Mobicam 3.9±0.02 0.1±0.012 17.26±0.13 25±0.1 20±0.2 1.57±0.1 
F2 3.7±0.03 0.13±0.015 19.21±0.2 53±0.5 22±0.12 1.89±0.18 
*SD standard deviation from mean, n=3, mean±SD. 
Table: 12. Dissolution Data of Optimized Piroxicam Fast Dissolving Tablets Employing Modified starch (F2) and 
Marketed Formulation 
Piroxicam Percent Dissolved from Fast Dissolving Tablets  
Time 
(Min) 
Mobicam F2 
5 84.18±0.11 85.12±0.2 
10 97.81±0.21 99.89±0.4 
*SD standard deviation from mean, n=3, mean±SD. 
 
 
Fig. 9: Dissolution Profiles of Optimized Piroxicam Fast 
Dissolving Tablets Employing Modified starch and 
Marketed Formulation. (F & Mobicam) 
 
Fig 10: Log Time Vs Log Percent Undissolved of 
optimized Piroxicam Fast Dissolving Tablets Employing 
Modified starch and marketed formulation (F2 & 
Mobicam)
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Table 13: Dissolution Parameters of Optimized Piroxicam Fast Dissolving Tablets Formulated Employing Modified 
starch (F2) and Marketed Formulation (Mobicam)  
Parameters Mobicam F2 
PD5 84.18±0.13 85.12 ± 0.74 
DE5 (%) 80.5 83.3 
K1 (min-1) 0.3316 0.3915 
*SD standard deviation from mean, n=3, mean±SD, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., K1 
=First order rate constant 
Fig: 9 Wetting Times of Optimized Piroxicam Fast Dissolving Tablets Employing Modified starch and marketed 
formulation (F2 & Mobicam) 
Piroxicam Fast Dissolving Tablets (Mobicam) 
 
 
At T=0 sec At T=33.67 sec 
F2 Piroxicam Fast Dissolving Tablets 
  
 
CONCLUSION: 
Modified starch is an efficient superdisintegrant for fast 
dissolving tablets. Drug release from the prepared tablets 
was rapid and is with in 10min and depended on the 
composition of the tablet i.e., concentration of modified 
starch, croscarmellose sodium and crospovidone. Based on 
the results obtained from polynomial equations and 
response surface methodology, the individual effects of  
modified starch (A), croscarmellose sodium (B) and 
crospovidone (C) and interaction between ABC are more 
significant and positive effect on dissolution efficiency in 5 
Response surface plots and contour plots indicated that the   
dissolution efficiency in 5 minutes of piroxicam fast 
dissolving tablets is influenced mostly by modified satrch, 
followed by  croscarmellose sodium and  crospovidone. Fast 
dissolving tablets (F2) formulated employing modified 
starch (5%), croscarmellose sodium (0%) and crospovidone 
(0%) exhibited rapid disintegration and fast release of drug 
with in 10 minutes. 
Optimization of piroxicam fast dissolving tablets is a 
complex process when a new starch based superdisintegrnt, 
modified starch is used as a superdisintegrant, which 
requires to consider a large number of variables and their 
interactions with each other. The present study conclusively 
demonstrates the use of 23– factorial design in optimization 
of piroxicam fast dissolving tablets. The derived polynomial 
equations and contour plots aid in predicting the values of 
selected independent variables for preparation of piroxicam 
fast dissolving tablets with desired properties.  
The optimized formulation (F2) gives the best result in 
terms of the required disintegration time, dissolution 
efficiency in 5 minutes, and drug release was in accordance 
with the USP dissolution criteria for conventional tablet of 
piroxicam drug. It is thus concluded that by adopting 
systematic approach, an optimum point can be reached in 
shortest time with minimum efforts when modified starch, is 
used as a superdisintegrant for achieving fast dissolving 
formulations. 
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